German and US Militaries Order £278 Million in Defence Products from Chemring

Chemring Lands Major Defence Contracts with Germany and the US, Securing £278 Million in New Orders

Editorial Team (ET)September 30, 2026

In a decisive stride forward, Chemring has secured high-value contracts with the German and US armed forces, amounting to a combined £278 million. The defense group’s recent announcement has sparked interest in the market, pushing its stock price upward by 1.7% on Monday. This wave of new orders not only underscores Chemring’s global reputation but also signifies a deepening commitment to supporting NATO allies through advanced defense solutions.

Chemring's Expansion and International Reach

With a presence that spans continents, Chemring continues to bolster its role as a key player in the defense industry. The group offers a wide range of defense technologies, from air engineering solutions to cybersecurity products, catering to various markets. The latest deals reinforce its established relationships in both Europe and North America.

Details of the German Armed Forces Contract

Chemring Nobel, a subsidiary in Norway, has secured a major contract with the German Armed Forces valued at €231 million (£194 million). This order will see Chemring Nobel supplying energetic materials essential for 155mm munitions, a critical component for defense forces. The five-year delivery schedule, commencing in late 2026, reflects a structured and long-term collaboration with Diehl Defence, underpinned by the partnership with Norwegian-Finnish defense giant Nammo AS.

Norwegian-Finnish Collaboration with Nammo AS

Nammo AS brings a unique blend of Norwegian and Finnish defense expertise, augmenting Chemring’s capabilities in Europe. This partnership not only facilitates Chemring’s entry into significant European defense contracts but also strengthens its alliance with NATO-member countries, ensuring supply chains for essential military materials remain robust and secure.

Energetic Materials for 155mm Munitions

In military parlance, energetic materials refer to substances like explosives or propellants, vital for ammunition and munitions. The 155mm munitions, in particular, are central to modern artillery. Used by NATO and allied forces, this caliber is known for its effectiveness in field operations, making Chemring’s contribution critical for Germany’s defense needs.

Chemring's US Missile Program Deal

On the other side of the Atlantic, Chemring’s US subsidiary has landed an order worth $106 million (£82 million) to deliver key components for an undisclosed US missile program. Set to begin in 2026, this five-year agreement bolsters Chemring’s footprint in the American defense sector and may pave the way for further collaborations with the US military.

Strategic Importance of the US Missile Components Contract

Chemring’s role in supplying missile components speaks volumes about its strategic positioning within the US defense industry. By focusing on components critical to missile programs, Chemring underscores its expertise in high-stakes defense technology, potentially securing a competitive edge for future US contracts.

Chemring's Diverse Defense Portfolio

Chemring’s range of offerings is extensive and designed to meet the evolving needs of global defense forces. From air engineering and reconnaissance systems to sophisticated cybersecurity solutions, the company’s diversified portfolio places it in an enviable position within the industry. This breadth allows Chemring to adapt quickly to various demands, reinforcing its market leadership.

Stock Performance and Financial Growth

Over the past five years, Chemring’s stock has surged by over 80%, a testament to investors’ confidence in its ability to deliver consistent growth. With Monday’s additional 1.7% increase following the latest contracts, the company continues to reflect robust demand in the defense sector, driven by geopolitical factors and growing military budgets worldwide.

Geopolitical Factors Driving Demand

The increasing number of geopolitical crises has compelled nations to ramp up their defense spending. Chemring is capitalizing on this trend, ensuring its offerings align with the security priorities of Western allies. This heightened demand has fueled Chemring’s growth trajectory, with recent investments aimed at expanding its production capacity.

CEO Michael Ord’s Statement on Contract Wins

Michael Ord, CEO of Chemring, remarked on the strategic importance of these contracts, highlighting the group’s longstanding relationships with defense clients. “These significant contract wins illustrate the deep long-term relationships that we have built with our customers,” he said, emphasizing how the new deals validate Chemring’s investment decisions to expand production.

Chemring's Investment in Production Capacity

In response to the surge in demand, Chemring has been scaling up its production capabilities. Notably, the group is expanding its three energetics businesses, aiming to meet the volume requirements set by recent contracts. These investments are also geared toward solidifying Chemring’s role as a primary NATO supplier.

Financial Expectations for the Year

As Chemring sets its sights on annual revenues of £1 billion, the group remains optimistic about meeting its profit projections of £70.8 million to £73.6 million. The recent orders, coupled with prior wins in the most recent quarter, point toward a strong close to the fiscal year.

Chemring's Role in NATO Defense Supply Chain

Chemring’s commitment to NATO goes beyond mere contracts. By providing critical defense components, the company reinforces its reputation as a trusted partner within the NATO supply chain, supporting collective defense efforts in an era marked by heightened security challenges.

Conclusion

Chemring’s recent deals with the German and US militaries highlight its role as a vital supplier in the defense sector. With growing demand, strategic partnerships, and a clear roadmap for expansion, Chemring is positioned for sustained growth. As defense budgets continue to rise globally, the company’s diversified portfolio and commitment to innovation make it a formidable player in the industry.

Disclaimer

This report should not be viewed as investment advice or as an offer to buy or sell any securities or as an invitation or solicitation of an offer to buy or sell any securities. Neither the author of this report, its publisher, nor any other person associated with the publication of this report, are registered brokers, investment dealers, investment advisers, or financial advisers. The information in this report has not been tailored to the particular needs or circumstances of readers and should not be relied upon as investment advice or recommendations to purchase or sell any of the securities presented in this report. Readers seeking investment advice should contact qualified and registered brokers, investment dealers, investment advisers, or financial advisers prior to making any decision to buy or sell any of the securities referred to in this report. The information in this report should not be construed as investment, legal, or tax advice. No recommendation is made as to whether an investment in the presented securities is suitable for any reader in light of the reader’s particular circumstances.

Readers are cautioned that the publisher of this report covers exclusively securities that carry a high degree of volatility. Investing in such securities is highly speculative and carries a high degree of risk. Investors in such securities could lose all or a substantial portion of their investment. Only those investors who can afford to lose all or a substantial portion of their investment should consider investing in the securities referred to in this report.

This report may include information obtained from publicly available sources, including third-party reports or analysis. Neither the author nor publisher of this report, nor www.juniorstocks.com or its owners, have undertaken any independent investigation into the factual information used in this report, and the information in this report is provided without any warranty of any kind. No representations or warranties are provided regarding the accuracy or completeness of the information provided in this report. Statements of opinion or belief are those of the authors and/or publisher of this report. These statements of opinion or belief are expressions of the author’s and/or publisher’s judgment, and there is no guarantee that those judgments will turn out to be correct. No inference should be drawn that the author and/or publisher have any special or greater knowledge about the presented companies or their securities, or any particular expertise in the industries or markets in which the company operates. Readers should conduct their own due diligence and seek professional advice prior to investing in any securities presented on Juniorstocks.com.

Certain statements in this report constitute “forward-looking” statements. Forward-looking statements often, but not always, are identified by the use of words such as “seek,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “targeting,” and “intend” and statements that an event or result “may,” “will,” “should,” “could,” or “might” occur or be achieved and other similar expressions. Forward-looking statements express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance; they are not statements of historical facts and should not be viewed as any guarantee of any future result. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The author and/or publisher of this report disclaims any obligation to update the forward-looking statements in this report, whether as a result of new information, future events, or results or otherwise. There is no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to applicable law or regulation, or would subject the author or publisher of this report to any registration requirement in such jurisdiction or country.

Information about the editor of this publication:
Juniorstocks.com is a service provided by Piccadilly Capital Group, Office 66, 101 Clapham High Street, London, SW4 7TB, UK. Piccadilly Capital Group is not the publisher of this report and was not paid for the publication of this report. Piccadilly Capital Group seeks to generate web traffic and a growing number of followers through the publication of articles or reports. Directors, officers, and other insiders of the publisher own an interest in Piccadilly Capital Group. Piccadilly Capital Group does not endorse or recommend the business, products, services, or securities of any company mentioned on www.juniorstocks.com. Piccadilly Capital Group will not share your information with any outside third parties. Due to the new data protection basic regulation, we ask you to read our data protection declaration carefully.

Note on copyright:
The contents published on this website and on connected media (e.g., e-mail, X, Facebook) are subject to applicable copyright and ancillary copyright laws. Any use not permitted by applicable copyright and ancillary copyright laws requires the prior written consent of the provider or the respective rights holder. In particular, this applies to the duplication, editing, translation, storage, processing, or reproduction of content in databases or other electronic media and systems. Contents and rights of third parties are marked as such. Unauthorized reproduction or transmission of individual contents or complete pages is not permitted and is punishable by law. Only the production of copies and downloads for personal, private, and non-commercial use is permitted. Links to the provider's website are always welcome and do not require the consent of the provider of the website. Photos and images on the website may not be shared unless the publisher itself has acquired the initial rights from authorized sources. The presentation of this website in external frames is only allowed with written permission. If you notice any violations, please inform us. Please note: The content of our articles, emails, or other publications or social networks such as X, LinkedIn or Facebook is exclusively intended for the designated addressee(s). If you are not the addressee of these articles, emails, or other publications in the market letter or social networks such as Twitter or Facebook or his or her legal representative, please note that any form of publication, reproduction, or distribution of the content of these articles, emails, or other publications in the market letter or social networks such as X, LinkedIn or Facebook is prohibited. Falsifications of the original content of this message during data transmission cannot be excluded in principle.